{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:49:02Z","timestamp":1761511742540},"reference-count":15,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2002,9,6]],"date-time":"2002-09-06T00:00:00Z","timestamp":1031270400000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[2002,9]]},"abstract":"<jats:p><jats:bold>Summary:<\/jats:bold> The anticonvulsant agent valproate (VPA) may cause hyperammonemic encephalopathy. Magnetic resonance imaging (MRI) and proton MR spectroscopic (MRS) findings in a patient with VPA\u2010induced hyperammonemic encephalopathy are described. MRI showed a metabolic\u2013toxic lesion pattern with bilateral T<jats:sub>2<\/jats:sub>\u2010hyperintense lesions in the cerebellar white matter and in the globus pallidus. MR spectroscopic findings were indistinguishable from hepatic encephalopathy with severe depletion of myoinositol and choline and with glutamine excess. <jats:italic>N<\/jats:italic>\u2010Acetylaspartate levels were moderately decreased. Quantitative MRS gave detailed insight into alterations of brain metabolism in VPA\u2010induced encephalopathy.<\/jats:p>","DOI":"10.1046\/j.1528-1157.2002.42201.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T20:03:01Z","timestamp":1047412981000},"page":"1101-1105","source":"Crossref","is-referenced-by-count":42,"title":["Valproate\u2010induced Encephalopathy: Assessment with MR Imaging and <sup>1<\/sup>H MR Spectroscopy"],"prefix":"10.1111","volume":"43","author":[{"given":"Sargon","family":"Ziyeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Spreer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Klisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,9,6]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(98)00075-6"},{"key":"e_1_2_5_3_2","first-page":"310","article-title":"Secondary hyperammonemia: a possible mechanism for valproate encephalopathy.","volume":"1","author":"Coulter DL","year":"1980","journal-title":"Lancet"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(05)81955-9"},{"key":"e_1_2_5_5_2","first-page":"1779","article-title":"Valproic acid\u2010induced hyperammonemic encephalopathy: MR appearance.","volume":"15","author":"Baganz MD","year":"1994","journal-title":"Am J Neuroradiol"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.1910300604"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.1940040205"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199910000-00019"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.3.365"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00711313"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.3.666"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002340050597"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840220111"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.1940040214"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-5945-0_12"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005437915117"}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1528-1157.2002.42201.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1528-1157.2002.42201.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T02:14:21Z","timestamp":1695867261000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1528-1157.2002.42201.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["10.1046\/j.1528-1157.2002.42201.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1528-1157.2002.42201.x","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}